Skip to main content
SpringerLink
Log in

Species differences in localization of cardiac cAMP-phosphodiesterase activity: A cytochemical study

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

The localization of the membrane-bound cyclic 3′,5′-AMP phosphodiesterasein cardiac tissues of both, rat and dog was studied by cytochemical method.40 µm thick slices from glutaraldehyde fixed heart tissue wereincubated in the medium with cAMP as a substrate and Pb ions as a capturemetal of the reaction product. The cAMP-PDE activity in the rat ventriclewas only shown positive on the sarcolemma. Whereas, in canine ventriculartissue the cAMP-PDE activity in cardiomyocytes was shown on the sarcolemma,on the junctional sarcoplasmic reticulum and on subsarcolemmal cisternae.The results confirm differences in the localization of cAMP-PDE in dog andrat heart.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Beavo JA, Reifsnyder DH: Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci 11: 150–155, 1990

    Google Scholar 

  2. Manganiello VC: Subcellular localization and biological function of specific cyclic nucleotide phosphodiesterases. J Mol Cell Cardiol 19: 1037–1040, 1987

    Google Scholar 

  3. Weishaar RE, Burrows SD, Kobylarz DC, Quade MM, Evans DB: Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and in platelets. Biochem Pharmacol 35: 787–800, 1986

    Google Scholar 

  4. Weishaar RE, Kobylarz-Singer DC, Steffen RP, Kaplan HR: Subclasses of cyclic AMP-specific phosphodiesterase in left ventricular muscle and their involvement in regulating myocardial contractility. Circ Res 61: 539–547, 1987a

    Google Scholar 

  5. Lugnier C, Schini VB: Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells. Biochem Pharmacol 39: 75–841, 1990

    Google Scholar 

  6. Ivorra MD, Le Bec A, Lugnier C: Characterization of membrane-bound cyclic-nucleotide phosphodiesterases from bovine aortic smooth muscle. J Cardiovasc Pharmacol 19: 532–540, 1992

    Google Scholar 

  7. Lugnier C, Muller B, Le Bec A, Beaudri C, Rousseau E: Cyclic nucleotide phosphodiesterase in canine and human cardiac microsomal fractions. J Pharmacol Exp Ther 265: 1142–1151, 1993

    Google Scholar 

  8. Komas N, Lugnier C, Stoclet JC: Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors. Br J Pharmacol 104: 495–503, 1991

    Google Scholar 

  9. Weishaar RE, Quade MM, Schenden JA, Evans B: Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics. J Cyclic Nucleotide Protein Phosphor Res 10: 551–564, 1985

    Google Scholar 

  10. Alvarez R, Banerjee GL, Bruno JJ, Jones GL, Lüttschwager K, Strosberg AM, Venuti MC: A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties. Mol Pharmacol 29: 554–560, 1986

    Google Scholar 

  11. Morgan JP, Gwathmey JK, Defeo TT, Morgan KG: The effects of amrinone and related drugs on intracellular calcium in isolated mammalian cardiac and vascular smooth muscle. Circulation 73 (Suppl. III): III65–III77, 1986

    Google Scholar 

  12. Muller B, Stoclet JC, Lugnier C: Cytosolic and membrane-bound cyclic nucleotide phosphodiesterases from guinea pig cardiac ventricles. Eur J Pharmacol 225: 263–272, 1992

    Google Scholar 

  13. Katano Y, Endoh M: Differential effects of RO 20-1724 and isobutylmethylxantine on the basal force of contraction and beta-adrenoceptorsmediated response in the rat ventricular myocardium. Biochem Biophys Res Commun 167: 123–128, 1990

    Google Scholar 

  14. Shahid M, Nicholson CD: Comparison of cyclic nucleotide phosphodiesterase isoenzymes in rat and rabbit ventricular myocardium: Positive inotropic and phosphodiesterase inhibitory effects of Org 30029, milrinone and rolipram. Naunyn-Schmied Arch Pharmacol 342: 698–704, 1990

    Google Scholar 

  15. Alousi A, Farah AK: Letter to the Editor. Circ Res 46: 887–888, 1980

    Google Scholar 

  16. Kobylarz DC, Steffen RP, Weishaar RE, Evans DB: Relationship between inhibition of ventricular peak III phosphodiesterase (PDE) and the in vivocardiotonic effect of CI-914 in several species [Abstract]. Pharmacologist 27: 683–689, 1985

    Google Scholar 

  17. Weishaar RE, Kobylarz-Singer DC, Kaplan HR: Subclasses of cyclic AMP phosphodiesterase in cardiac muscle. J Mol Cell Cardiol 16: 1025–1036, 1987b

    Google Scholar 

  18. Komas N, Lugnier C, Stoclet JC: Pharmacological characterization of membrane-bound forms of cAMP phosphodiesterase from cardiac tissue. J Mol Cell Cardiol 22 (Suppl. 4): S32–S38, 1990

    Google Scholar 

  19. Vrbjar N, Le Bec A, Lugnier C: Localization of cyclic nucleotide phosphodiesterase III and IV in purified canine cardiac sarcolemma [Abstract]. J Mol Cell Cardiol 26XII: 5.7, 1994

    Google Scholar 

  20. Sugimura K, Mizutani A. Electron-microscopic cytochemical study of cyclic nucleotide phosphodiesterase in rat brain. Histochemistry 55: 97–105, 1978

    Google Scholar 

  21. Schulze W: Methods for histochemical localization of adenylate cyclase and guanylate cyclase in heart membrane. In: NS Dhalla (ed). Methods Studying Cardiac Membranes. Vol. II. Florida: CRS Press, Inc Boca Raton, 1984, pp 83–97

    Google Scholar 

  22. Slezak J, Geller SA: Cytochemical demonstration of adenylate cyclase in cardiac muscle. Effect of dimethylsulfoxide. J Histochem Cytochem 27: 774–781, 1979

    Google Scholar 

  23. Slezak J, Tribulova N: Subcellular localization of adenylate cyclase and guanylate cyclase in heart muscle cells. Histochem J 16: 380–382, 1984

    Google Scholar 

  24. Okruhlicova L, Slezak J: The effect of calmodulin inhibitors of adenylate cyclase system. Physiol Bohemoslov 39: 240–244, 1990

    Google Scholar 

  25. Shahid M, Wilson M, Nicholson CD, Marshall RJ: Species-dependent differences in the properties of particulate cyclic nucleotide phosphodiesterase from rat and rabbit ventricular myocardium. J Pharm Pharmacol 42: 282–288, 1990

    Google Scholar 

  26. Okruhlicová L, Tribulová N, Eckly A, Lugnier C, Slezak J: Cytochemical distribution of cyclic AMP-dependent 3?,5?-nucleotide phosphodiesterase in the rat myocardium. Histochem J 28: 165–172, 1996

    Google Scholar 

  27. Endo M: Calcium release from the SR. Physiol Rev 57: 71–108, 1977

    Google Scholar 

  28. Fabiato A: Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am J Physiol 245: C1–C14, 1983

    Google Scholar 

  29. Poeggel G, Luppa H, Schmidt A: Histochemistry of cyclic nucleotide phosphodiesterase in nervous tissue III. Enzyme cytochemical investigations. Acta Histochem Cytochem 21: 473–480, 1988

    Google Scholar 

  30. Prigent AF, Fougier S, Nemoz G, Anger G, Pacheco H, Lugnier C, Le Bec A, Stoclet JC: Comparison of cyclic nucleotide phosphodiesterase isoforms from rat heart and bovine aorta: Separation and inhibition by selective reference phosphodiesterase inhibitors. Biochem Pharmacol 37: 3671–3681, 1988

    Google Scholar 

  31. Tribulová N, Slezák J, Ravingerová T, Pavlíkova D, Okruhlicová B: Cytochemical approaches to the conducting system of the heart in normal and pathological conditions. [Abstract] Histochem J 24: 292, 1992

    Google Scholar 

  32. Tribulová N, Okruhlicová L', Ziegelhöffer B, Slezák J: Ultrastructure and cytochemistry of the developing rat myocardium in normal and ischemic conditions. In: Abstracts: ‘Progress in Basic, Applied and Diagnostic Histochemistry’, Olomouc, 1994a, p 94

  33. Tribulova N, Ziegelhoffer B, Slezak J: Histochemical characterization of the developing rat myocardium in physiologic and ischemic conditions. In: S Hanusho, K Kjeldsen (eds). Proceedings of XV European Section Meeting of the International Society for Heart Research 1994b: pp 711–715

  34. Borgers M, Thone F: Species differences in adenosine metabolic sites in the heart. Histochem J 24: 445–452, 1992

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovak Repahlic

    L'udmila Okruhlicová, Narcisa Tribulová, Ján Styk & Ján Slezák

  2. Laboratoire de Pharmacologie et Physiologie Cellulaires-CNRS, Université L. Pasteur de Strasbourg, Illkirch, France

    Anita Eckly & Claire Lugnier

Authors
  1. L'udmila Okruhlicová
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Narcisa Tribulová
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ján Styk
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anita Eckly
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Claire Lugnier
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ján Slezák
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Okruhlicová, L., Tribulová, N., Styk, J. et al. Species differences in localization of cardiac cAMP-phosphodiesterase activity: A cytochemical study. Mol Cell Biochem 173, 183–188 (1997). https://doi.org/10.1023/A:1006845513962

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006845513962

Search

Navigation